NYSE - Nasdaq Real Time Price USD

Arcus Biosciences, Inc. (RCUS)

8.52
-0.15
(-1.73%)
As of 3:33:48 PM EDT. Market Open.
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
1,150,000
1,095,000
1,345,000
1,592,000
Total Liabilities Net Minority Interest
665,000
633,000
688,000
750,000
Total Equity Gross Minority Interest
485,000
462,000
657,000
842,000
Total Capitalization
533,000
462,000
657,000
842,000
Common Stock Equity
485,000
462,000
657,000
842,000
Capital Lease Obligations
12,000
11,000
3,000
116,887
Net Tangible Assets
485,000
462,000
657,000
842,000
Working Capital
790,000
647,000
874,000
1,096,000
Invested Capital
533,000
462,000
657,000
842,000
Tangible Book Value
485,000
462,000
657,000
842,000
Total Debt
60,000
11,000
3,000
116,887
Share Issued
92,200
75,500
72,900
70,781.74
Ordinary Shares Number
92,200
75,500
72,900
70,781.74
12/31/2021 - 3/15/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ITOS iTeos Therapeutics, Inc.
7.53
-4.14%
 
ORIC ORIC Pharmaceuticals, Inc.
4.8950
-7.82%
 
SNDX Syndax Pharmaceuticals, Inc.
9.48
-6.97%
 
IDYA IDEAYA Biosciences, Inc.
17.23
-1.26%
 
APGE Apogee Therapeutics, Inc.
39.52
-0.55%
 
NRIX Nurix Therapeutics, Inc.
9.57
-1.64%
 
BCYC Bicycle Therapeutics plc
8.06
-0.62%
 
REPL Replimune Group, Inc.
6.94
-6.41%
 
KURA Kura Oncology, Inc.
5.72
-1.38%
 
DAWN Day One Biopharmaceuticals, Inc.
6.24
-1.50%